Welcome to China Surfactant Detergent & Cosmetics, Today is

China Surfactant Detergent & Cosmetics ›› 2025, Vol. 55 ›› Issue (6): 723-730.doi: 10.3969/j.issn.2097-2806.2025.06.006

• Development and application • Previous Articles     Next Articles

Skin sensitisation in vitro method: kinetic direct peptide reactivity assay (kDPRA) transformation and validation

Ting Liu,Shibu Liu,Li Zhang,Hui Duo,Yong Lu*(),Luyong Zhang*()   

  1. National Institutes for Food and Drug Control, Beijing 102629, China
  • Received:2024-06-06 Revised:2025-05-26 Online:2025-06-22 Published:2025-07-01
  • Contact: E-mail: luyong@nifdc.org.cn (Yong Lu); zhangluyong@nifdc.org.cn (Luyong Zhang).

Abstract:

The in vitro method kinetic direct peptide reactivity assay (kDPRA) for skin sensitisation is the first key event (KE1) for modelling the skin sensitisation adverse outcome pathway (AOP): covalent binding of electrophilic substances to nucleophilic centres of skin proteins. Based on the reactivity of tested substance and cysteine, the logarithm of the maximum rate constant (lg kmax) of the tested substance was calculated by detecting the amount of peptide remaining after incubation with different concentrations of the tested substance at six time points, which is used to support the discrimination of UN GHS subcategory 1A skin sensitisers (GHS 1A). This method has not yet been reported in China. The effect of different fluorescence efficacy monobromobimane on the test was examined. Seven compounds with known sensitising strengths were selected to validate the predictive accuracy of the kDPRA. The results show that the effect of different brands of monobromobimane on the prediction results can be accepted. The prediction of allergenicity for the 7 substances is consistent with the known classification, and that kDPRA can accurately identify the subcategory 1A skin sensitisers.

Key words: skin sensitisation, in vitro, kinetic direct peptide reactivity assay, validation

CLC Number: 

  • TQ658